Contract

Bourn Hall Level 3 Fertility Services 2020-2023

  • NHS NORFOLK AND WAVENEY INTEGRATED CARE BOARD

F20: Modification notice

Notice identifier: 2025/S 000-050420

Procurement identifier (OCID): ocds-h6vhtk-058bde

Published 21 August 2025, 10:19am



Section one: Contracting authority/entity

one.1) Name and addresses

NHS NORFOLK AND WAVENEY INTEGRATED CARE BOARD

8th Floor, County Hall, Martineau Lane

Norwich

NR12DH

Email

nwicb.contractsandprocurement@nhs.net

Country

United Kingdom

Region code

UKH15 - Norwich and East Norfolk

NHS Organisation Data Service

26A

Internet address(es)

Main address

https://improvinglivesnw.org.uk/


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Bourn Hall Level 3 Fertility Services 2020-2023

Reference number

2526-113

two.1.2) Main CPV code

  • 85111310 - In vitro fertilisation services

two.1.3) Type of contract

Services

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKH11 - Peterborough
  • UKH12 - Cambridgeshire CC
  • UKH17 - Breckland and South Norfolk
  • UKH34 - Essex Haven Gateway
  • UKH37 - Essex Thames Gateway

two.2.4) Description of the procurement at the time of conclusion of the contract:

Provision of specialist fertility services for patients fulfilling the eligibility criteria including:

In Vitro Fertilisation (IVF) with or without Intra-cytoplasmic Sperm Injection (ICSI)

Frozen Embryo Transfer

Embryo/Blastocyst Freezing and Storage (Gametes)

Surgical sperm recovery (Testicular Epididymal Sperm Aspiration (TESA) / Percutaneous Sperm Aspiration (PESA) including storage where required)

Intrauterine Insemination (IUI) unstimulated

Donor Oocyte Cycle

Donor Sperm Insemination, with IVF/IUI. Donor insemination in following conditions: obstructive azoospermia, nonobstructive azoospermia, severe deficits in semen quality in couples who do not wish to undergo ICSI, where there is a high risk of transmitting a genetic disorder to the offspring, where there is a high risk of transmitting infectious disease to the offspring or woman from the man.

Oocyte retrieval for patients undergoing cancer treatments - includes first years' storage.

Oocyte or sperm annual storage for patients undergoing cancer treatment.

two.2.7) Duration of the contract, framework agreement, dynamic purchasing system or concession

Duration in months

36


Section four. Procedure

four.2) Administrative information

four.2.1) Contract award notice concerning this contract

Notice number: 2099/S 001-999999


Section five. Award of contract/concession

Contract No

2099 /S 001-999999

five.2) Award of contract/concession

five.2.1) Date of conclusion of the contract/concession award decision:

1 April 2020

five.2.2) Information about tenders

The contract/concession has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor/concessionaire

Bourn Biosciences Ltd

Cambridge

Country

United Kingdom

NUTS code
  • UKH12 - Cambridgeshire CC
NHS Organisation Data Service

AY7

The contractor/concessionaire is an SME

No

five.2.4) Information on value of the contract/lot/concession (at the time of conclusion of the contract;excluding VAT)

Total value of the procurement: £3,719,000


Section six. Complementary information

six.3) Additional information

This is a Provider Selection Regime (PSR) contract modification notice, under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2024 do not apply to this award. This contract has been formally modified.

Modification approved by ICB Interim Executive Director of Finance.

No conflicts of interest were declared.

six.4) Procedures for review

six.4.1) Review body

NHS Norfolk and Waveney Integrated Care Board (ICB)

Norwich

Country

United Kingdom


Section seven: Modifications to the contract/concession

seven.1) Description of the procurement after the modifications

seven.1.1) Main CPV code

  • 85111310 - In vitro fertilisation services

seven.1.3) Place of performance

NUTS code
  • UKH11 - Peterborough
  • UKH12 - Cambridgeshire CC
  • UKH17 - Breckland and South Norfolk
  • UKH34 - Essex Haven Gateway
  • UKH37 - Essex Thames Gateway

seven.1.4) Description of the procurement:

This modification extends the contract for a period of 8 months from 1 August 2025 to 31 March 2026.

This is to allow time for a PSR compliant process to be identified and completed for a subsequent award.

seven.1.5) Duration of the contract, framework agreement, dynamic purchasing system or concession

End date

31 March 2026

seven.1.6) Information on value of the contract/lot/concession (excluding VAT)

Total value of the contract/lot/concession:

£3,719,000

seven.1.7) Name and address of the contractor/concessionaire

Bourn Biosciences Ltd

Cambridge

Country

United Kingdom

NUTS code
  • UKH12 - Cambridgeshire CC
NHS Organisation Data Service

AY7

The contractor/concessionaire is an SME

No

seven.2) Information about modifications

seven.2.1) Description of the modifications

Nature and extent of the modifications (with indication of possible earlier changes to the contract):

This modification extends the contract term by 8 months:

Original contract 01/04/2020-31/03/2023

Optional 2 year extension used 01/04/2023-31/03/2025

Previous Contract modification 01/04/2025-31/07/2025

This Contract modification 01/08/2025-31/03/2026

The modification is made at the discretion of the relevant authority and the modification does not render the contract or framework agreement materially different in character and the cumulative change in the lifetime value of the contract or framework agreement, compared to its value when it was entered into, is under 25%.

seven.2.2) Reasons for modification

Need for additional works, services or supplies by the original contractor/concessionaire.

Description of the economic or technical reasons and the inconvenience or duplication of cost preventing a change of contractor:

Extension of existing contract term to new end date of 31 March 2026, permissible in line with Section 13 - 2A and 2B (ii) of The Health Care Services (Provider Selection Regime) Regulations 2023.

The modification does not render the contract or framework agreement materially different in character and the cumulative change in the lifetime value of the contract or framework agreement since it was entered into or concluded is less than 25% of the lifetime value of the original contract or framework agreement when it was entered into or concluded

seven.2.3) Increase in price

Updated total contract value before the modifications (taking into account possible earlier contract modifications, price adaptions and average inflation)

Value excluding VAT: £4,009,123

Total contract value after the modifications

Value excluding VAT: £4,589,369